Mirxes Announces HK$711 Million Placing Agreement at HK$32.50 per share, 40% above IPO price
January 29, 2026
SINGAPORE, January 29, 2026 – Mirxes Holding Company Limited (“Mirxes” or the “Company”, Stock Code: 2629.HK), a leading and only publicly-listed molecular cancer early detection company in Asia Pacific, is